Now FDA Approved
Introducing TALZENNA®, a once-daily oral treatment.
TALZENNA is a prescription medicine used to treat adults with:
- a certain type of breast cancer (human epidermal growth factor receptor 2 [HER2]-negative), and
- an abnormal inherited BRCA gene, and
- whose cancer has spread to other parts of the body (locally advanced or metastatic).
Your healthcare provider will perform a test to make sure that TALZENNA is right for you.
It is not known if TALZENNA is safe and effective in children.
Pfizer Oncology TogetherTM
Making Your Support Needs A Priority. Together.
Eligible, commercially insured patients may pay as little as $0 per month for TALZENNA.* There are no income requirements, forms, or faxing to enroll. To find out more, call
*Limits, terms, and conditions apply. This card is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, Tricare or other federal or state healthcare programs and the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $25,000 in savings annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. For any questions, please call